Nucleotide sequence encoding the tumor rejection antigen precursor, MAGE-1
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Aug 30, 1994
Issued Date -
N/A
app pub date -
Dec 12, 1991
filing date -
May 23, 1991
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The invention relates to an isolated DNA sequence which codes for an antigen expressed by tumor cells which is recognized by cytotoxic T cells, leading to lysis of the tumor which expresses it. Also described are cells transfected by the DNA sequence, and various therapeutic and diagnostic uses arising out of the properties of the DNA and the antigen for which it codes.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully